⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Angal Biotechnologies Ltd. and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Angal Biotechnologies Ltd.
↗Suzhou, China
Angal Biotechnologies (AngalBio) is an innovative biotech company established in 2019 in Suzhou, China. It operates as a joint venture between JLP Health GmbH (Austria), the Jiangsu Industrial Technology Research Institute, and Suzhou New District Hi-Tech Industrial Co., Ltd. The company focuses on precision drug target deconvolution, genetic screening, and the development of first-in-class therapies for oncology, viral infections, and metabolic/neurodegenerative diseases.
AngalBio utilizes a dual-engine strategy involving technology transfer from its parent company, JLP Health, and external licensing agreements. Its platform includes haploid cell-based genetic screening and AI-assisted drug discovery. The company is actively building a pipeline of antisense oligonucleotide (ASO) candidates and natural compound-based therapies.
CLASSIFICATION
Company Type:Biotech
Therapeutic Areas:
Industry:Biotechnology
Sub-Industry:Oncology biotech, CNS therapeutics, Antivirals
SIZE & FINANCIALS
Employees:1-50
Founded:2019
Ownership:private
Status:operating
FUNDING
Stage:Series A
Investors:Suzhou Hi-Tech Angel Venture Capital Management
PIPELINE
Stage:Preclinical
Lead Drug Stage:Preclinical
Modalities:Antisense oligonucleotide (ASO), Small molecule
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Parent Company:JLP Health GmbH
Key Partnerships:JLP Health GmbH (Parent/Technology partner), Neurovision Pharma GmbH (Licensing partner for TGFBRII ASO), Kunming Institute of Botany (Research collaboration)
COMPETITION
Position:Emerging
LEADERSHIP
Key Executives:
Liqun Zhang - CEO
Matheus Dyczynski - CSO
LINKS
Website:angalbio.com
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Angal Biotechnologies Ltd.. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.